W John Smither

Affiliations

  • at Genelux Corp (GNLX), 2024-08-05
  • Chief Financial Officer at Arcutis Biotherapeutics Inc. (ARQT), 2024-02-15
  • at Newamsterdam Pharma Co N.v. (NAMS), 2024-01-03
  • Director at Applied Molecular Transport Inc. (AMTI), 2023-12-28
  • Director at Effector Therapeutics Inc. (EFTR), 2023-06-23
  • Director at Principia Biopharma Inc. (PRNB), 2019-02-21
  • Chief Financial Officer at Sienna Biopharmaceuticals Inc. (SNNA), 2019-01-03
  • Director at Achaogen Inc (AKAO), 2018-06-07
  • Chief Financial Officer at Kythera Biopharmaceuticals Inc (KYTH), 2015-10-02
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GNLX $0.00 6,250 13,170 2024-05-29 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
GNLX $20.78 900 Director 6,920 2023-09-13 Filing
ARQT $32.90 1,250 Officer 86,715 2021-03-10 Filing
ARQT $32.90 500 Officer 46,321 2021-03-10 Filing
ARQT $34.20 773 Officer 24,425 2021-03-01 Filing
ARQT $35.64 2,000 Officer 87,965 2021-02-10 Filing